Location Rocky Hill, Connecticut, United States Regions East Coast, New England, Northeastern US Gender Male
LinkedIn View on LinkedIn
Russell has invested in more than 50 companies during his tenure at CI. He has led CI’s investments in bioscience companies including Affomix Corporation, Cardiopulmonary Corporation, Genaissance Pharmaceuticals, Ipsogen and Metagenomix, Inc. Russell has also led CI’s investments in I-Mark and LiveClips and serves on the boards of Advent, AxioMx,
EpiEP, LiQuifix, LiveClips and Soft Tissue Regeneration. Seven of the current or former CI portfolio companies in which Russell invested have had successful initial public offerings.
Russell has considerable experience in economic and venture analysis, engineering cost accounting, systems analysis, scientific and commercial programming, math analysis, EDP auditing and computer modeling. He was previously with United Technologies Corp., Wolf Research and Development, Scientific Leasing, and the Robert E. Nolan Co.
Russell holds a bachelor of science degree in electrical engineering and a master of business administration degree from the University of Hartford.
